Analysis reveals rising mortality due to hypertensive diseases in women, highlighting racial and regional disparities.
Background: Hypertensive diseases (HD) remain a persistent contributor to cardiovascular mortality among women in the USA. Despite national efforts to improve BP control, long-term mortality patterns in women reveal disparities that are often masked in sex-aggregated data.A focused analysis is essential to guide gender-responsive public health strategies. Method: We utilized the CDC WONDER underlying Cause of Death database to examine age-adjusted mortality rates due to HD among U.S. women(1990-2020). Annual Percentage Change(APC) was calculated using log-linear regression models.Temporal patterns were further analyzed across race,age,and region to identify disparities&shifts in mortality burden. Result: Between 1999 and 2020,total deaths due to HD rose from 25,803 to 61,574,reflecting an annual increase of 3.37%,while the age-adjusted mortality rate climbed from 15.2(95% UI:15.0–15.4) to 25.5(25.3–25.7) per 100,000, with an APC of 1.56%.From 1999-2020, the highest rise in mortality was observed in hypertensive heart and renal disease with Congestive HF (APC: +18.09%),followed by unspecified hypertensive heart and renal disease (+10.96%), while essential hypertension showed a steady increase (APC: +3.43%). In terms of Census region, the highest rise observed in the Northeast (APC: +1.82%), followed by the Midwest (+1.67%), West (+1.45%), and South (+1.33%). From 1999 to 2020, HD mortality rose among Hispanic or Latino (APC: +1.06%) and Not Hispanic or Latino populations (APC:+1.67%). Based on 2013 urbanization level, highest increased observed in NonCore Nonmetro areas (APC:+2.76%) and Micropolitan regions (+2.11%), followed by Medium Metro (+1.74%), Small Metro (+1.73%), Large Fringe Metro (+1.38%), and Large Central Metro (+1.23%). Based on racial groups, the highest rise observed among American Indian or Alaska Native (APC: +2.66%) and White populations (+2.05%), a modest increase in Asian or Pacific Islanders (+0.65%), while a slight decline was observed in Black or African Americans (APC: −0.44%). In terms of age group, highest rise observed in the 55–64 years (APC: +5.53%),65–74 years (+4.03%), and 85+ years (+3.89%), while a slight decline was noted in the 15–24 years group (APC: −0.58%). Conclusion: From 1999-2020,HD mortality in women rose substantially, with sharp increases in deaths tied to cardio-renal complications, older age, and rural settings.These trends demand urgent,targeted strategies to mitigate future burden and close emerging disparities.
No takes yet. Share an insight, caveat, or question.
Abubaker et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: